# Quartz Crystal Microbalance-Based Biosensor for Rapid and Ultrasensitive SARS-CoV-2 Detection

> Source page: https://openqcm.com/scientific-papers/quartz-crystal-microbalance-based-biosensor-for-rapid-and-ultrasensitive-sars-cov-2-detection
> Markdown version for AI agents and readers of plain text. Site guide: https://openqcm.com/llms.txt · Everything in one file: https://openqcm.com/llms-full.txt

- Authors: Sahera Saleh, Habib Alkalamouni, Karen Antar, Joe Rahme, Michel Kazan, Pierre Karam, Jit Muthuswamy, Hassan Zaraket, Massoud L Khraiche
- Journal: Journal of Pharmaceutical and Biomedical Analysis Open
- Year: 2025
- Volume: 5
- Pages: 100071
- DOI: 10.1016/j.jpbao.2025.100071
- Instrument used: openQCM Sensors, openQCM Wi2

## Abstract

The COVID-19 pandemic highlighted the urgent need for rapid, sensitive, and affordable diagnostic tests, especially in resource-limited settings. While RT-qPCR remains the gold standard for SARS-CoV-2 detection, it is expensive and requires specialized equipment. Antigen-based tests, though faster, lack sufficient sensitivity. Therefore, there is a pressing need for a platform that combines the rapidity of antigen tests with the sensitivity of molecular tests. In this work, we address this problem by developing a Quartz Crystal Microbalance (QCM) biosensor for the rapid detection of SARS-CoV-2 nucleocapsid proteins. We designed a QCM biosensor with polyethylene glycol (PEG)-based surface functionalization, which significantly improves sensitivity and specificity. The platform achieved a detection limit of 53.3 TCID50/mL and a sensitivity of 0.263Hz/ TCID50 /mL, with results available in approximately 15minutes. Cross-reactivity tests with Influenza A demonstrated its high specificity for SARS-CoV-2. Comprehensive surface characterization using Scanning Electron Microscopy (SEM), Digital Holographic Microscopy, and Raman Spectroscopy confirmed the stability and integrity of the functionalized sensor surface. The platform is cost-effective, scalable, and designed for ease of use in resource-limited settings. This work presents the first open-source QCM biosensing platform for SARS-CoV-2 detection that combines high sensitivity, rapid results, and affordability. It offers a deployable solution for COVID-19 diagnostics, particularly in underserved regions, and is adaptable for future pandemic preparedness.

---

openQCM by Novaetech S.r.l., Pompeii, Italy · Buy: https://store.openqcm.com/ · Contact: info@openqcm.com · https://openqcm.com/contacts/